Healthcare > Medical Devices & Equipment
•1105 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (1105)
| Company | Market Cap | Price |
|---|---|---|
|
IRMD
IRadimed Corporation
The MRidium MRI-compatible patient vital signs monitoring system qualifies as patient monitoring equipment in MRI environments.
|
$1.23B |
$97.04
+0.84%
|
|
AMPH
Amphastar Pharmaceuticals, Inc.
Inhalation systems and advanced formulations imply medical device components bridging drug delivery.
|
$1.22B |
$26.32
+4.16%
|
|
PCRX
Pacira BioSciences, Inc.
IOvera is a medical device product, placing Pacira in the Medical Devices & Biometrics category.
|
$1.20B |
$26.69
+1.52%
|
|
BLFS
BioLife Solutions, Inc.
Sells consumables such as hPL, CellSeal vials, and CryoCase used within CGT workflows.
|
$1.18B |
$24.65
+1.07%
|
|
NNE
Nano Nuclear Energy Inc
Company engages in laboratory testing/advisory services related to nuclear tech development and regulatory readiness.
|
$1.18B |
$31.39
-11.35%
|
|
STAA
STAAR Surgical Company
STAAR directly manufactures ophthalmic medical devices, primarily implantable lenses (EVO ICL) used for vision correction.
|
$1.17B |
$23.57
-2.34%
|
|
UCTT
Ultra Clean Holdings, Inc.
Provides laboratory testing and advisory services relevant to semiconductor manufacturing cleanliness and optimization.
|
$1.16B |
$25.66
-1.48%
|
|
XERS
Xeris Biopharma Holdings, Inc.
Prefillable Syringes describe a major packaging format used for injectable drugs in Xeris's portfolio.
|
$1.14B |
$7.06
-1.53%
|
|
THRM
Gentherm Incorporated
Medical devices & biometrics including patient temperature management devices.
|
$1.14B |
$37.26
+0.92%
|
|
EYPT
EyePoint Pharmaceuticals, Inc.
Implantable ophthalmic device component due to bioerodible Durasert E delivery system.
|
$1.13B |
$16.39
+2.50%
|
|
CSTL
Castle Biosciences, Inc.
Provides laboratory-based molecular diagnostic testing and related advisory services directly to clinicians.
|
$1.13B |
$38.91
+0.71%
|
|
INMD
InMode Ltd.
InMode's core business is medical devices and biometrics, with RF-based aesthetic platforms and related systems.
|
$1.10B |
$14.34
-1.21%
|
|
OPK
OPKO Health, Inc.
OPKO's BioReference segment provides laboratory testing and advisory services.
|
$1.07B |
$1.35
-2.17%
|
|
CDNA
CareDx, Inc
Directly provides Laboratory Testing & Advisory Services through its testing portfolio and diagnostic operations.
|
$1.06B |
$19.92
-3.11%
|
|
MDXG
MiMedx Group, Inc.
Directly manufactures and sells wound care devices and placental tissue allografts (EPIFIX, EPICORD, EPIEFFECT) used in wound healing.
|
$1.05B |
$7.13
-1.25%
|
|
IART
Integra LifeSciences Holdings Corporation
Wound care/regenerative product portfolio (IDRT, PriMatrix, SurgiMend, DuraSorb, MediHoney) constitutes major product lines.
|
$1.05B |
$13.48
+0.45%
|
|
SPRY
ARS Pharmaceuticals, Inc.
Neffy includes a needle-free delivery device, aligning with Medical Devices & Biometrics.
|
$1.05B |
$10.61
+3.61%
|
|
SSII
SS Innovations International, Inc.
Core product: robotic surgical system and endo-surgical instruments (SSi Mantra and related tools) sold as surgical equipment.
|
$985.37M |
$5.04
-8.11%
|
|
NUTX
Nutex Health, Inc.
Nutex Health operates micro-hospitals and provides hospital services including acute inpatient care and emergency/observation services.
|
$978.34M |
$174.37
-5.69%
|
|
MEG
Montrose Environmental Group, Inc.
Laboratory testing and advisory services as part of Montrose's measurement and analysis offerings.
|
$952.74M |
$27.03
+1.20%
|
|
PLSE
Pulse Biosciences, Inc.
Pulse Biosciences develops nsPFA-based medical devices (e.g., CellFX platform) for non-thermal tissue ablation across soft tissue and cardiac indications.
|
$950.64M |
$14.11
-0.91%
|
|
MRVI
Maravai LifeSciences Holdings, Inc.
Biologics safety testing kits and related analytical services (e.g., residual DNA quantification, Protein L assays) are direct BST offerings.
|
$937.18M |
$3.67
+2.08%
|
|
ALNT
Allient Inc.
Medical Device Components align with Allient’s product capabilities used in medical device applications.
|
$932.59M |
$55.20
-0.36%
|
|
CRMD
CorMedix Inc.
DefenCath is an FDA-approved antimicrobial catheter-lock device marketed by CorMedix.
|
$845.77M |
$11.34
-1.35%
|
|
MATW
Matthews International Corporation
Memorialization segment includes embalming chemicals and funeral supplies (memorialization products).
|
$826.74M |
$26.86
+1.24%
|
|
FLGT
Fulgent Genetics, Inc.
Laboratory testing and advisory services.
|
$824.00M |
$26.93
-0.79%
|
|
BFLY
Butterfly Network, Inc.
Core ultrasound imaging hardware and point-of-care devices (POCUS) produced by Butterfly.
|
$810.61M |
$3.21
+6.81%
|
|
CBLL
CeriBell, Inc.
Ceribell's core product is a point-of-care diagnostic EEG system (diagnostic equipment).
|
$802.94M |
$21.86
+4.44%
|
|
SIBN
SI-BONE, Inc.
SI-BONE operates as a medical device company that designs, develops and sells orthopedic implants and related medical devices.
|
$794.22M |
$18.41
-1.00%
|
|
CLB
Core Laboratories N.V.
CLB provides laboratory testing and advisory services via proprietary tracers and reservoir analysis capabilities.
|
$776.09M |
$16.64
+0.97%
|
|
PSNL
Personalis, Inc.
NeXT Personal is a tumor-informed liquid biopsy-based MRD test, central to PSNL's offerings.
|
$751.98M |
$8.48
-3.31%
|
|
KE
Kimball Electronics, Inc.
KE's medical device and biometrics manufacturing capabilities are central to its strategy.
|
$720.50M |
$29.81
-1.75%
|
|
EMBC
Embecta Corp.
Embecta operates as a medical device company focused on insulin injection devices, including pen needles, syringes, and safety products.
|
$698.90M |
$11.90
-0.42%
|
|
MYGN
Myriad Genetics, Inc.
Laboratory testing and advisory services; Myriad operates clinical labs delivering diagnostic tests.
|
$650.38M |
$7.00
-2.91%
|
|
PACB
Pacific Biosciences of California, Inc.
PacBio directly manufactures diagnostic sequencing equipment (instruments) used in molecular diagnostics and research laboratories.
|
$636.79M |
$2.13
+0.47%
|
|
TCMD
Tactile Systems Technology, Inc.
Core medical devices for lymphedema and airway clearance (Flexitouch Plus, Nimbl, AffloVest) are manufactured and sold by the company.
|
$633.77M |
$28.41
+2.10%
|
|
OFIX
Orthofix Medical Inc.
Core product category covering orthopedic implants and surgical devices, including spinal hardware.
|
$620.45M |
$15.71
+1.45%
|
|
BVS
Bioventus Inc.
Bioventus designs and manufactures medical devices and biometrics solutions for musculoskeletal health.
|
$620.09M |
$7.51
-0.46%
|
|
SRDX
Surmodics, Inc.
Surmodics' vascular intervention devices (SurVeil DCB, Pounce thrombectomy, Sublime radial access) are a core product category sold by the company.
|
$614.58M |
$42.98
|
|
ORGO
Organogenesis Holdings Inc.
Core wound care device category covering Apligraf and Dermagraft, along with barrier products like PuraPly and FortiShield.
|
$612.72M |
$4.83
+0.31%
|
|
CTKB
Cytek Biosciences, Inc.
Cytek's instrument manufacturing includes flow cytometry diagnostic equipment, the core product line referenced in the article.
|
$590.32M |
$4.62
-4.84%
|
|
LAB
Standard BioTools Inc.
SomaScan laboratory testing and advisory services are a core direct offering.
|
$576.81M |
$1.52
+4.83%
|
|
AVNS
Avanos Medical, Inc.
Avanos produces surgical equipment including radiofrequency ablation (RFA) systems and related devices used in procedures.
|
$550.33M |
$11.88
+1.11%
|
|
ANGO
AngioDynamics, Inc.
Broad investable theme for medical devices & biometrics, aligning with AngioDynamics' device-centric business.
|
$542.06M |
$13.36
+1.67%
|
Showing page 5 of 12 (1105 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
